Aclaris Therapeutics Inc (ACRS)
1.36
+0.05
(+3.82%)
USD |
NASDAQ |
May 03, 16:00
1.355
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Free Cash Flow: -79.63M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -79.63M |
| September 30, 2023 | -91.65M |
| June 30, 2023 | -74.98M |
| March 31, 2023 | -73.94M |
| December 31, 2022 | -68.17M |
| September 30, 2022 | -66.23M |
| June 30, 2022 | -68.92M |
| March 31, 2022 | -61.34M |
| December 31, 2021 | -52.44M |
| September 30, 2021 | -44.03M |
| June 30, 2021 | -45.82M |
| March 31, 2021 | -44.39M |
| December 31, 2020 | -39.09M |
| September 30, 2020 | -50.88M |
| June 30, 2020 | -62.60M |
| March 31, 2020 | -73.38M |
| December 31, 2019 | -98.06M |
| Date | Value |
|---|---|
| September 30, 2019 | -104.80M |
| June 30, 2019 | -111.03M |
| March 31, 2019 | -111.60M |
| December 31, 2018 | -102.17M |
| September 30, 2018 | -93.56M |
| June 30, 2018 | -77.13M |
| March 31, 2018 | -65.21M |
| December 31, 2017 | -55.90M |
| September 30, 2017 | -45.24M |
| June 30, 2017 | -41.23M |
| March 31, 2017 | -40.76M |
| December 31, 2016 | -34.84M |
| September 30, 2016 | -30.97M |
| June 30, 2016 | -31.70M |
| March 31, 2016 | -24.93M |
| December 31, 2015 | -20.88M |
Free Cash Flow Range, Past 5 Years
-111.03M
Minimum
Jun 2019
-39.09M
Maximum
Dec 2020
-69.02M
Average
-68.17M
Median
Dec 2022
Free Cash Flow Benchmarks
| Aldeyra Therapeutics Inc | -30.33M |
| Akoya Biosciences Inc | -54.55M |
| CEL-SCI Corp | -23.45M |
| AIM ImmunoTech Inc | -21.85M |
| IGC Pharma Inc | -6.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.761M |
| Cash from Investing (Quarterly) | 7.55M |
| Cash from Financing (Quarterly) | 0.049M |
| Free Cash Flow Per Share (Quarterly) | -0.1016 |
| Free Cash Flow to Equity (Quarterly) | -7.202M |
| Free Cash Flow Yield | -83.89% |